Company intelligence / Profile preview

Microfluidics International

Westwood, Massachusetts, United States

Ownership: Private
Employees: ~7000
Development stage: Other

Overview

Microfluidics International does not develop therapeutics directly, but its Microfluidizer processor technology is commercially deployed for a wide range of pharmaceutical and biopharma manufacturing needs—such as cell disruption, micro- and nanoemulsions, and particle size reduction, supporting clients in drug development and production across vaccines, cancer therapeutics, antibiotics, and more[1][3][4][5].

Modalities: Device
Industry: Drug Discovery Services

Partnerships

IDEX Material Processing Technologies divisionGlobal channel partners (regional agents/distributors)

Beyond the preview

Go deeper on Microfluidics International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microfluidics International.

Explore the full profile